Who
Omar Ishrak
Director
Company insider
Files Form 4 as: Director, Amgen; Director, Intel; Director, Allurion Technologies; Executive Chairman, Medtronic plc; Chairman & CEO, Medtronic.
In numbers
- Trades disclosed
- 146
- Buys
- 5
- Sells
- 10
- Bought
- $3.5M
- Sold
- $31.9M
- Companies
- 5
- Companies where not an officer
- 3
- First trade
- 13 Jun 2011
- Last trade
- 7 Aug 2026
- Last filed
- 10 Aug 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 7 Aug 2026filed 10 Aug 2026 | AMGN AmgenBiotechnology | SEC FORM 4 Code A | —85.169 at $0.00 | filing |
| 7 Aug 2026filed 10 Aug 2026 | AMGN AmgenBiotechnology | SEC FORM 4 Code A | —85.17 at $0.00 | filing |
| 19 May 2026filed 21 May 2026 | AMGN AmgenBiotechnology | SEC FORM 4 Code A | —665 at $0.00 | filing |
| 19 May 2026filed 21 May 2026 | AMGN AmgenBiotechnology | SEC FORM 4 Code A | —665 at $0.00 | filing |
| 5 May 2026filed 7 May 2026 | AMGN AmgenBiotechnology | SEC FORM 4 Code A | —106.193 at $0.00 | filing |
| 5 May 2026filed 7 May 2026 | AMGN AmgenBiotechnology | SEC FORM 4 Code A | —106.19 at $0.00 | filing |
| 7 Nov 2025filed 12 Nov 2025 | AMGN AmgenBiotechnology | SEC FORM 4 Code A | —218.61 at $0.00 | filing |
| 8 Aug 2025filed 12 Aug 2025 | AMGN AmgenBiotechnology | SEC FORM 4 Code A | —121.43 at $0.00 | filing |
| 23 May 2025filed 28 May 2025 | AMGN AmgenBiotechnology | SEC FORM 4 Code A | —809 at $0.00 | filing |
| 6 May 2025filed 8 May 2025 | AMGN AmgenBiotechnology | SEC FORM 4 Code A | —129.42 at $0.00 | filing |
| 28 Mar 2025filed 1 Apr 2025 | INTC Inteloption or derivative · Semiconductors | SEC FORM 4 Code A | $31K1,376.05 at $22.71 | filing |
| 27 Dec 2024filed 31 Dec 2024 | INTC Inteloption or derivative · Semiconductors | SEC FORM 4 Code A | $31K1,539.41 at $20.30 | filing |
| 4 Nov 2024filed 6 Nov 2024 | AMGN AmgenBiotechnology | SEC FORM 4 Code A | —220.88 at $0.00 | filing |
| 27 Sep 2024filed 1 Oct 2024 | INTC Inteloption or derivative · Semiconductors | SEC FORM 4 Code A | $31K1,306.99 at $23.91 | filing |
| 9 Aug 2024filed 13 Aug 2024 | AMGN AmgenBiotechnology | SEC FORM 4 Code A | —108.53 at $0.00 | filing |
| 28 Jun 2024filed 2 Jul 2024 | INTC Inteloption or derivative · Semiconductors | SEC FORM 4 Code A | $31K1,009.04 at $30.97 | filing |
| 31 May 2024filed 4 Jun 2024 | AMGN AmgenBiotechnology | SEC FORM 4 Code A | —719 at $0.00 | filing |
| 8 May 2024filed 10 May 2024 | INTC Inteloption or derivative · Semiconductors | SEC FORM 4 Code A | —7,403 | filing |
| 7 May 2024filed 8 May 2024 | AMGN AmgenBiotechnology | SEC FORM 4 Code A | —116.55 at $0.00 | filing |
| 28 Mar 2024filed 2 Apr 2024 | INTC Inteloption or derivative · Semiconductors | SEC FORM 4 Code A | $26K594.3 at $44.17 | filing |
News
Floating-Point Addition And Subtraction On Intel's 8087INTC · hackaday.com · 22 Oct 2026Steelwork Advances at Intel's Ohio Site as Fab Operations Target 2030–31INTC · econotimes.com · 22 Oct 2026Medtronic announces positive results from real-world registries for the Sphere-9™ catheter and PulseSelect™ PFA System at APHRS 2026MDT · prnewswire.com · 22 Oct 2026Acer TravelLite TL44-53M-G2 Launched in India with Intel Core Ultra Series 3 ChipINTC · themobileindian.com · 22 Oct 20268th Circ. Panel Doubts Investors' Medtronic Insulin Pump SuitMDT · law360.com · 21 Oct 2026Medtronic: How an Olympic Runner Found Relief From Fecal IncontinenceMDT · finanznachrichten.de · 19 Oct 2026
0 headlines in the last 90 days name Omar Ishrak; 6 articles from the last 14 days about the 2 companies they traded most, at most three about any one of them.